Catalyst Wire Dossier Catalyst Wire Dossier

Lurbinectedin

lurbinectedin · PharmaMar
Drug timelines are a Plus or Pro feature.

28 regulatory and trial events tracked for Lurbinectedin, covering 2015-11-05 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo) [Phase 3]

See pricing